Sacubitril and valsartan

Product NDC
31722-673
11-digit product format
317220673
Labeler code
31722
Product ID
31722-673_3a93c356-cfa8-4c31-e063-6394a90a536a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Sacubitril and valsartan
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Camber Pharmaceuticals, Inc.
Application
ANDA213668
Marketing category
ANDA
Marketing start
2025-07-23
Substance
SACUBITRIL; VALSARTAN
Active strength
24; 26 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213668-001SACUBITRIL AND VALSARTANSACUBITRIL; VALSARTAN24MG;26MGTABLET / ORALAB2025-07-17
A213668-002SACUBITRIL AND VALSARTANSACUBITRIL; VALSARTAN49MG;51MGTABLET / ORALAB2025-07-17
A213668-003SACUBITRIL AND VALSARTANSACUBITRIL; VALSARTAN97MG;103MGTABLET / ORALAB2025-07-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A213668-001AB
A213668-002AB
A213668-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A213668-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-1784e616aacf4f…
2026-09-14 22:38:342026-08A213668-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-1784e616aacf4f…
2026-09-14 22:38:342026-08A213668-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-1784e616aacf4f…
2026-08-18 06:07:402026-07A213668-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-17caaa826d4ba7…
2026-08-18 06:07:402026-07A213668-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-17caaa826d4ba7…
2026-08-18 06:07:402026-07A213668-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213668-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213668-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213668-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213668-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213668-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213668-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08A213668-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213668-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213668-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-176a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213668-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-17a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213668-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-17a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213668-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-17a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A213668-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A213668-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A213668-003AB184e616aacf4f…
2026-08-18 06:07:402026-07A213668-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A213668-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A213668-003AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213668-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213668-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213668-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213668-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213668-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213668-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A213668-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213668-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213668-003AB16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213668-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213668-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213668-003AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Sacubitril and valsartan
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SACUBITRIL24 mg/1
VALSARTAN26 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
80M03YXJ7IInternal UNII lookup
17ERJ0MKGIInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1656340Internal RxNorm lookup
1656349Internal RxNorm lookup
1656354Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
65a3e298-279d-4498-a7be-5f9ee5bc77d8Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
692a3434-fece-49c6-9b7d-ed7aefc52b50Product name320260317
b15e9aa6-d523-ca97-480e-570e0543a342Product name420251024
265792b3-b999-c010-7364-a7db20b9d4d9Product name520250515
e7dfdaab-7cf9-4f89-804c-eff5108d94d1Product name920250305
b6abae2f-ee27-47bc-b150-54dc8d969483Product name220250221
52311e76-a520-4bd2-9d5b-e0b6d6f44519Product name220231208
a8e65197-7914-7acf-c7ec-914d53819b34Product name320190624
f5231d08-c52b-a5a0-ba93-675895c292beProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
31722-673-18Sacubitril and valsartan180 in 1 BOTTLETABLET, FILM COATED1802
31722-673-60Sacubitril and valsartan60 in 1 BOTTLETABLET, FILM COATED602

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
31722-673-18EA - Each31722-673fa367608-6ab8-4194-9f3e-24b60605fa5212025-08-11
31722-673-60EA - Each31722-673bb59fcdf-5d36-4000-82f2-b13b4c86087e12025-08-11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sacubitril and valsartanSACUBITRIL AND VALSARTANCamber Pharmaceuticals, Inc.65a3e298-279d-4498-a7be-5f9ee5bc77d82025-07-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213668
application number: ANDA213668
ndc (product): 31722-673

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1656340sacubitril 24 MG / valsartan 26 MG Oral TabletPSN65a3e298-279d-4498-a7be-5f9ee5bc77d82
1656349sacubitril 49 MG / valsartan 51 MG Oral TabletPSN65a3e298-279d-4498-a7be-5f9ee5bc77d82
1656354sacubitril 97 MG / valsartan 103 MG Oral TabletPSN65a3e298-279d-4498-a7be-5f9ee5bc77d82
1656340sacubitril 24 MG / valsartan 26 MG Oral TabletSCD65a3e298-279d-4498-a7be-5f9ee5bc77d82
1656349sacubitril 49 MG / valsartan 51 MG Oral TabletSCD65a3e298-279d-4498-a7be-5f9ee5bc77d82
1656354sacubitril 97 MG / valsartan 103 MG Oral TabletSCD65a3e298-279d-4498-a7be-5f9ee5bc77d82

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
31722-673-1831722067318180 TABLET, FILM COATED in 1 BOTTLE (31722-673-18) 2025-07-23NoNoCurrent
31722-673-603172206736060 TABLET, FILM COATED in 1 BOTTLE (31722-673-60) 2025-07-23NoNoCurrent